CPA
CVS icon

Court Place Advisors’s CVS Health CVS Stock Holding History

Court Place Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.18M Sell
28,970
-793
-3% -$54.3K 0.66% 34
2025
Q2 		$2.05M Sell
29,763
-579
-2% -$38K 0.65% 36
2025
Q1 		$2.06M Sell
30,342
-1,763
-5% -$106K 0.68% 36
2024
Q4 		$1.44M Sell
32,105
-13,595
-30% -$763K 0.47% 48
2024
Q3 		$2.87M Sell
45,700
-833
-2% -$48.6K 0.84% 30
2024
Q2 		$2.75M Buy
46,533
+145
+0.3% +$9.07K 0.86% 29
2024
Q1 		$3.7M Sell
46,388
-4,630
-9% -$354K 1.19% 22
2023
Q4 		$4.03M Sell
51,018
-894
-2% -$63.6K 1.32% 19
2023
Q3 		$3.62M Buy
51,912
+1,159
+2% +$82.1K 1.29% 18
2023
Q2 		$3.51M Sell
50,753
-1,846
-4% -$131K 1.23% 20
2023
Q1 		$3.91M Buy
52,599
+1,573
+3% +$132K 1.42% 18
2022
Q4 		$4.76M Buy
51,026
+474
+0.9% +$45.7K 1.72% 13
2022
Q3 		$4.82M Sell
50,552
-317
-0.6% -$31.4K 1.94% 12
2022
Q2 		$4.71M Buy
50,869
+1,200
+2% +$117K 1.78% 11
2022
Q1 		$5.03M Sell
49,669
-4,546
-8% -$478K 1.62% 13
2021
Q4 		$5.59M Sell
54,215
-2,189
-4% -$202K 1.54% 15
2021
Q3 		$4.79M Buy
56,404
+1,194
+2% +$100K 1.42% 16
2021
Q2 		$4.61M Sell
55,210
-512
-0.9% -$41.9K 1.34% 17
2021
Q1 		$4.19M Buy
55,722
+177
+0.3% +$12.9K 1.3% 16
2020
Q4 		$3.79M Buy
55,545
+1,702
+3% +$111K 1.27% 18
2020
Q3 		$3.14M Buy
53,843
+1,154
+2% +$71.8K 1.18% 20
2020
Q2 		$3.42M Buy
52,689
+965
+2% +$60.8K 1.33% 18
2020
Q1 		$3.07M Buy
51,724
+9,920
+24% +$662K 1.38% 19
2019
Q4 		$3.11M Buy
41,804
+5,442
+15% +$382K 1.12% 26
2019
Q3 		$2.29M Buy
36,362
+791
+2% +$46.9K 0.89% 32
2019
Q2 		$1.94M Buy
35,571
+11,018
+45% +$593K 0.76% 36
2019
Q1 		$1.32M Buy
24,553
+3,391
+16% +$209K 0.53% 49
2018
Q4 		$1.39M Buy
21,162
+18,242
+625% +$1.36M 0.63% 43
2018
Q3 		$230K Buy
+2,920
New +$209K 0.09% 159

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Court Place Advisors's CVS Position: Q3 2025 in Review

Court Place Advisors reduced its CVS Health (CVS) stake by 2.7% in Q3 2025, selling an estimated $54.3K and leaving 28,970 shares worth $2.18M. The position accounts for 0.66% of the portfolio, ranked #34.

Court Place Advisors first reported a position in CVS in Q3 2018 and has held it in 29 quarters since. The position peaked at $5.59M in Q4 2021. 1,835 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • Court Place Advisors held 28,970 shares of CVS Health worth $2.18M as of Q3 2025.
  • Court Place Advisors sold 793 CVS Health shares in Q3 2025, an estimated $54.3K.
  • CVS Health made up 0.66% of Court Place Advisors's portfolio in Q3 2025, its #34 holding.
  • Court Place Advisors first reported a position in CVS Health in Q3 2018 and has held it in 29 quarters since.
  • Court Place Advisors's CVS Health position peaked at $5.59M in Q4 2021.
  • 1,835 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Court Place Advisors's 13F filing for Q3 2025, filed 25 Nov 2025.